MOESM9 of Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort

Roderick Slieker, Amber Heijden, Giel Nijpels, Petra Elders, Leen 'T Hart, Joline Beulens
2019 Figshare  
Additional file 9: Figure S4. Glucose-lowering treatments across HbA1c-CV quintiles. a–e Percentage of individuals per quintile untreated (a), on metformin only (b), combination of metformin and SU (c), SU monotherapy (d) and insulin (e). f–h Odds ratios of the four highest quintiles versus the lowest quintile across time for (f) metformin (g) sulphonylureas and (h) insulin. Abbreviations: SU, sulphonylureas.
doi:10.6084/m9.figshare.11364137 fatcat:3fc7ouj4ebgm7bpl7a3rifjj7i